Loading...
XNAS
SINT
Market cap4mUSD
Jul 09, Last price  
1.70USD
1D
-5.03%
1Q
-36.57%
Jan 2017
-100.00%
IPO
-100.00%
Name

SINTX Technologies Inc

Chart & Performance

D1W1MN
XNAS:SINT chart
P/E
—
P/S
4.63
EPS
—
Div Yield, %
—
Shrs. gr., 5y
73.89%
Rev. gr., 5y
11.38%
Revenues
1m
-18.30%
20,261,45523,065,27222,314,00022,765,00019,453,00015,226,00011,227,00095,000689,000594,000606,000601,0002,627,0001,246,0001,018,000
Net income
-17m
L+54.96%
-23,751,170-35,034,669-8,286,000-32,582,000-23,912,000-16,598,000-9,329,000-8,652,000-4,797,000-7,029,000-9,309,000-12,039,000-8,259,000-11,024,000-17,083,000
CFO
-9m
L-0.82%
-14,907,757-9,730,162-9,949,000-14,522,000-9,063,000-7,170,000-4,680,000-9,348,000-6,435,000-9,112,000-10,127,000-10,263,000-14,115,000-8,642,000-8,571,000
Earnings
Aug 03, 2026

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Sintx Technologies, Inc. is an advanced materials enterprise dedicated to researching, developing, and commercializing medical devices crafted from silicon nitride. These innovative products serve biomedical, industrial, and antipathogenic uses, primarily marketed across the United States. Its diverse portfolio includes solid and porous silicon nitride, silicon nitride powder, and specialized coating products, along with advanced silicon nitride composite materials and polyetherketoneketone. Established in 1996, this company, once known as Amedica Corporation, has its corporate headquarters situated in Salt Lake City, Utah.
URL
https://sintx.com/
IPO date
Feb 11, 2014
Employees
41
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT